LeMaitre to Present at the Bank of America Healthcare Conference

Rhea-AI Summary

LeMaitre Vascular (Nasdaq: LMAT) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 5:15 PM PT. Management presentation details and timing are provided for investors and analysts ahead of the event.

News Market Reaction – LMAT

+0.03%

+0.03% Session close to close

In the May 8 session, LMAT gained 0.03%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights LMAT management’s upcoming presentation at a major healthcare conferenc...

Analysis

This announcement highlights LMAT management’s upcoming presentation at a major healthcare conference, adding to a steady cadence of investor outreach following recent strong quarters. Filings show higher Q1 2026 sales of $66.6 million, improved gross margin of 72.7%, and a raised quarterly dividend of $0.25 plus a $100 million buyback authorization. Investors may watch future earnings, capital allocation updates, and additional conference appearances for confirmation of growth and profitability trends.

Key Figures

Q1 2026 net sales: $66.6 million Q1 2026 gross margin: 72.7% Q1 2026 net income: $15.7 million +5 more

8 metrics

Q1 2026 net sales $66.6 million Reported in 10-Q for first quarter 2026

Q1 2026 gross margin 72.7% Improved gross margin in 10-Q

Q1 2026 net income $15.7 million Net income growth vs. prior year quarter

Q1 2026 diluted EPS $0.68 Diluted EPS reported in 10-Q

Q1 2026 operating cash flow $15.1 million Operating cash flow from 10-Q

Short-term marketable securities $340.4 million Balance at quarter end in 10-Q

Convertible senior notes $172.5 million 2.50% notes due 2030 from 10-Q

Quarterly dividend $0.25 per share Dividend level described in 10-Q/8-K

Historical Context

5 past events · Latest: May 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 05	Q1 2026 earnings	Positive	-1.6%	Reported Q1 2026 sales, margin, earnings growth and capital return plans.
Apr 14	Earnings date notice	Neutral	-2.2%	Announced timing and access details for Q1 2026 earnings release.
Apr 07	Conference presentation	Neutral	+1.1%	Disclosed management presentation at Needham Virtual Healthcare Conference.
Feb 27	Multiple conferences	Neutral	-4.8%	Outlined participation in five March 2026 investor conferences and meetings.
Feb 25	Q4 2025 earnings	Positive	+24.4%	Reported strong Q4 2025 growth, higher margins, and raised capital returns.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent strong earnings updates showed mixed immediate reactions, with one quarter up sharply and the latest quarter seeing a modest decline, while conference announcements have produced relatively small, directionally varied moves.

Recent Company History

Over the last few months, LeMaitre reported strong financial momentum, including Q4 2025 results that drove a 24.41% one-day gain and Q1 2026 results with higher sales, margins, and earnings, though shares slipped 1.59% afterward. The company boosted its dividend to $0.25 and authorized a $100M buyback. Alongside earnings, LMAT has regularly announced participation in investor and healthcare conferences, which generally produced smaller day‑to‑day price moves compared with major earnings releases.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact: 
Sandra Millar
 LeMaitre Vascular, Inc. 
+1-781-425-1686 
smillar@lemaitre.com

FAQ

When will LeMaitre Vascular (LMAT) present at the Bank of America Healthcare Conference?

LeMaitre Vascular will present on Wednesday, May 13, 2026 at 5:15 PM PT. According to the company, management scheduled this presentation to discuss recent developments and engage with investors and analysts at the conference.

How can investors watch LeMaitre Vascular (LMAT) presentation on May 13, 2026?

Investors can typically access a live webcast or replay via the company investor site or conference portal. According to the company, presentation access details are usually posted on LeMaitre Vascular's investor relations page before the event.

What topics will LeMaitre Vascular (LMAT) management cover at the conference on May 13, 2026?

Management will cover recent company developments and strategic outlook during the presentation. According to the company, the session is intended for investors and analysts and may include business updates, market context, and Q&A if scheduled.

Will LeMaitre Vascular (LMAT) provide a replay of the May 13, 2026 presentation?

LeMaitre Vascular commonly posts replays after conference presentations on its investor relations site. According to the company, a webcast replay and presentation slides are often made available following the live session for investor review.

Who from LeMaitre Vascular (LMAT) is likely to present at the Bank of America Healthcare Conference?

Presenters are typically senior management such as the CEO or CFO representing the company. According to the company, management will present on May 13, 2026, though specific presenter names are announced by the company when available.